Table 1.

Demographic Characteristics of Patients

Patient	Age	Pap resulta	Smoking statusb	Contraception statusc	HPV DNA in CVL	PSA status of CVLd	HIV-1 p24 in CVL (MALDI TOF PMF)
1	46	LGSIL	Nonsmoker	Tubal ligation	Positive type 58	Positive	Positive
2	27	ASCUS	Nonsmoker	Condom	Positive type 16	Negative	Negative
3	37	ASCUS	Nonsmoker	Tubal ligation	Negative	Positive	Positive
4	22	Negative for CIN	Nonsmoker	Intrauterine device	Negative	Not analyzed	Negative
5	25	LGSIL	Nonsmoker	Condom	Positive type 72	Negative	Negative
6	50	LGSIL	Nonsmoker	Condom	Positive type 39	Negative	Positive
7	34	LGSIL	Nonsmoker	Condom	Negative	Positive	Negative
8	46	HGSIL	Smoker	Condom	Negative	Negative	Negative
9	20	LGSIL	Nonsmoker	Condom	Positive type 18	Positive	Negative
10	25	ASCUS	Nonsmoker	Pills	Positive type 33	Positive	Negative
11	22	ASCUS	Nonsmoker	Pills	Positive type 59	Negative	Negative
12	21	ASCUS	Nonsmoker	Pills	Positive type 16	Negative	Negative
13	21	ASCUS	Nonsmoker	Pills	Negative	Positive	Negative
14	23	Negative for CIN	Smoker	Pills	Negative	Not analyzed	Negative
15	40	LGSIL	Nonsmoker	Pills	Negative	Negative	Positive
16	25	HGSIL	Nonsmoker	Pills	Positive type 62	Not analyzed	Negative
17	31	ASCUS	Nonsmoker	Condom	Negative	Negative	Negative
18	18	ASCUS	Nonsmoker	Condom	Positive type 16	Not analyzed	Negative
19	36	Negative for CIN	Nonsmoker	Tubal ligation	Negative	Positive	Negative
20	24	Negative for CIN	Nonsmoker	Pills	Positive type 16	Negative	Negative

^aLGSIL/HGSIL, low/high grade squamous intraepithelial lesion; ASCUS, atypical cells of unknown significance.

^bSmokers smoked ½ to 2 packs a day for at least 1 year.

^cWomen on contraceptive pills for at least a period of 6 months and on other various forms of contraception.

^dThe PSA status of four CVL samples was not determined because fresh CVL was not available when PSA assays could be done.